CA2042972A1 - Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour administration oculaire - Google Patents

Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour administration oculaire

Info

Publication number
CA2042972A1
CA2042972A1 CA2042972A CA2042972A CA2042972A1 CA 2042972 A1 CA2042972 A1 CA 2042972A1 CA 2042972 A CA2042972 A CA 2042972A CA 2042972 A CA2042972 A CA 2042972A CA 2042972 A1 CA2042972 A1 CA 2042972A1
Authority
CA
Canada
Prior art keywords
ocular
treatment
synergistic combination
hypertension
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2042972A
Other languages
English (en)
Other versions
CA2042972C (fr
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of CA2042972A1 publication Critical patent/CA2042972A1/fr
Application granted granted Critical
Publication of CA2042972C publication Critical patent/CA2042972C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002042972A 1990-05-22 1991-05-21 Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour administration oculaire Expired - Lifetime CA2042972C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP132909/1990 1990-05-22
JP13290990 1990-05-22

Publications (2)

Publication Number Publication Date
CA2042972A1 true CA2042972A1 (fr) 1991-11-23
CA2042972C CA2042972C (fr) 1996-10-15

Family

ID=15092362

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002042972A Expired - Lifetime CA2042972C (fr) 1990-05-22 1991-05-21 Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour administration oculaire

Country Status (8)

Country Link
US (1) US5208256A (fr)
EP (1) EP0458588B1 (fr)
JP (1) JPH0798751B2 (fr)
AT (1) ATE114470T1 (fr)
CA (1) CA2042972C (fr)
DE (1) DE69105349T2 (fr)
DK (1) DK0458588T3 (fr)
ES (1) ES2067864T3 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364884A (en) * 1993-01-21 1994-11-15 Baylor College Of Medicine Arginine compounds as ocular hypotensive agents
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
EP1007028A4 (fr) * 1997-05-09 2002-06-05 Traitement du glaucome a base de 8-iso-prostaglandines
CA2444627A1 (fr) * 2001-05-14 2002-11-21 Sucampo Ag Methode de traitement de l'hypertension oculaire et du glaucome
CA2458230A1 (fr) * 2001-08-23 2003-03-06 Sucampo Ag Procede et composition pour le traitement de l'hypertension oculaire et du glaucome
US8580851B2 (en) * 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
US20040076678A1 (en) * 2002-08-21 2004-04-22 Sucampo Ag Opthalmic solution
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
JP4648340B2 (ja) * 2006-02-07 2011-03-09 株式会社アールテック・ウエノ １５−ケトプロスタグランジンｅ誘導体の製造法
EP1985298A1 (fr) 2007-04-24 2008-10-29 Azad Pharma AG Émulsions ophtalmiques eau dans l'huile contenant des prostaglandines
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
MX2013011894A (es) * 2011-04-12 2014-02-27 Polyactiva Pty Ltd Analogos de prostaglandina conjugados con polimeros.
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062964A (en) * 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
JPS52154528A (en) * 1976-05-31 1977-12-22 Kaken Pharmaceut Co Ltd Remedy for glaucoma
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
ES2053458T3 (es) * 1986-03-13 1994-08-01 Univ Columbia Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
US4822820A (en) * 1986-11-24 1989-04-18 Alcon Laboratories, Inc. Use of tri-methyl PG-F2 a and derivatives in glaucoma therapy
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
EP0580268B1 (fr) * 1988-10-01 1998-01-14 R-Tech Ueno Ltd. Agents oculaires hypotenseurs

Also Published As

Publication number Publication date
US5208256A (en) 1993-05-04
JPH0798751B2 (ja) 1995-10-25
ATE114470T1 (de) 1994-12-15
ES2067864T3 (es) 1995-04-01
JPH04253910A (ja) 1992-09-09
DE69105349T2 (de) 1995-04-06
CA2042972C (fr) 1996-10-15
EP0458588B1 (fr) 1994-11-30
DE69105349D1 (de) 1995-01-12
EP0458588A1 (fr) 1991-11-27
DK0458588T3 (da) 1995-03-13

Similar Documents

Publication Publication Date Title
CA2042972A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour administration oculaire
CA2004239A1 (fr) Utilisation de l'acetyl-d-carnitine dans le traitement therapeutique du glaucome et composes pharmaceutiques utiles dans un tel traitement
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
IL101883A0 (en) Antiviral combinations and pharmaceutical compositions containing them
AU1398892A (en) Pyrazolopyridine compound and processes for preparation thereof
ZA898667B (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment
CA2046069A1 (fr) Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
CA2042934A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique oculaire
IL93594A0 (en) Pharmaceutical compositions containing an imidazopyrimidone derivative
CA2042936A1 (fr) Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour utilisation ophtalmique
CA2030344A1 (fr) Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines
CA2065889A1 (fr) Augmentation du debit choroidien
CA2061907A1 (fr) Traitement de l'hypertension oculaire avec combinaison synergique
EP0613375A4 (fr) Compositions polypetidiques pharmaceutiques contenant de la lysine et procedes d'utilisation desdites compositions.
EP0351876A3 (fr) Composition pour augmenter l'effet de vaccination
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
CA2135752A1 (fr) Utilisation de la (e)-2-(p-fluorophenethyl)-3-fluoroallylamine dans le traitement de la maladie d'alzheimer
CA2176392A1 (fr) Utilisation de derives de 2-aminopurine dans le traitement et la prophylaxie des infections par l'herpesvirus 7 humain
CA2167926A1 (fr) Utilisation de benzydamine pour le traitement d'un etat pathologique cause par le tnf
GB8719670D0 (en) Pharmaceutical compositions
CA2176376A1 (fr) Utilisation de derives de 2-amino purine utilises dans le traitement et la prophylaxie des infections dues a l'herpesvirus 6 chez l'homme
EP0621789A4 (en) Pharmaceutical pentapeptide compositions and methods of use thereof.
MY110416A (en) Composition for the treatment of schizophrenia.
GR3031360T3 (en) Composition based on ibuprofen, for oral usage
ITMI931598A1 (it) Uso terapeutico della fosfocreatina

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry